Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel compounds acting on urate transporter patented by Ardea Bisociences

Jan. 19, 2012

Ardea Biosciences discloses new inhibitors of urate transport

Jan. 18, 2012

LoneStar Heart acquires exclusive worldwide license

Jan. 17, 2012

Boehringer Ingelheim and Vitae Pharmaceuticals patent new 11-beta-HSD1 inhibitors

Jan. 17, 2012

Merck & Co. presents new GPR119 receptor agonists

Jan. 17, 2012

Researchers at Sanofi prepare novel endothelial lipase inhibitors

Jan. 17, 2012

Spherix completes SPX-106 toxicology study for IND submission

Jan. 16, 2012

Pfizer presents new glucokinase activators

Jan. 16, 2012

Chinese company patents novel PPAR agonists

Jan. 16, 2012

Stem Cell Educator therapy evaluated in patients with type 1 diabetes

Jan. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...